
MONA is a Belgian healthcare AI startup focused on transforming retinal screening for diabetes-related eye conditions like diabetic retinopathy (DR). Their AI-driven software, compatible with most fundus cameras, enables nurses or technicians to conduct screenings, reducing bottlenecks and improving patient access. MONA's algorithm screens retinal images for early signs of DR and diabetic maculopathy, providing results within seconds. The entire screening process takes approximately 3 minutes, offering a more comfortable and efficient experience for patients and freeing up ophthalmologists' time for treatment. The company leverages deep learning algorithms trained on over 273,000 retinal images, achieving high sensitivity and specificity in detecting these conditions.

MONA is a Belgian healthcare AI startup focused on transforming retinal screening for diabetes-related eye conditions like diabetic retinopathy (DR). Their AI-driven software, compatible with most fundus cameras, enables nurses or technicians to conduct screenings, reducing bottlenecks and improving patient access. MONA's algorithm screens retinal images for early signs of DR and diabetic maculopathy, providing results within seconds. The entire screening process takes approximately 3 minutes, offering a more comfortable and efficient experience for patients and freeing up ophthalmologists' time for treatment. The company leverages deep learning algorithms trained on over 273,000 retinal images, achieving high sensitivity and specificity in detecting these conditions.
Headquarters: Leuven, Belgium
Product: AI software-as-a-medical-device for automated retinal screening (diabetic retinopathy & maculopathy)
Clinical dataset: Models trained/validated on >273,000 retinal images
Speed: Provides screening results within seconds; screening process ~3 minutes
Company size (reported): 4 employees
Diabetic eye disease screening (diabetic retinopathy and diabetic maculopathy)
Healthtech / Medical AI
1760000.00
“Supported by KULeuven and the Health Unit of VITO”